The present invention relates to a novel use of therapeutic agents for prostatic hyperplasia, alpha-blockers. According to the present invention, it has verified that alpha-blockers, which are known therapeutic agents for prostatic hyperplasia, have an effect in the treatment of gastroesophageal reflux disease as well. According to the present invention, alpha-blockers of the therapeutic agent for prostatic hyperplasia can be beneficially used as therapeutic agents for gastroesophageal reflux disease.COPYRIGHT KIPO 2017알파차단제를 위식도 역류질환 치료제로 이용하는 용도특허권
